Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designs.

Favalli EG, Bugatti S, Biggioggero M, Caporali R.

Biomed Res Int. 2014;2014:831603. doi: 10.1155/2014/831603. Epub 2014 Apr 16. Review.

2.

Review of head-to-head study designs in rheumatoid arthritis.

R F, R L, J S S.

Semin Arthritis Rheum. 2016 Dec;46(3):279-285. doi: 10.1016/j.semarthrit.2016.07.006. Epub 2016 Aug 1. Review.

3.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
4.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

5.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Clark W, Jobanputra P, Barton P, Burls A.

Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.

6.

Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis.

Desai RJ, Hansen RA, Rao JK, Wilkins TM, Harden EA, Yuen A, Jonas DE, Roubey R, Jonas B, Gartlehner G, Lux L, Donahue KE.

Ann Pharmacother. 2012 Nov;46(11):1491-505. doi: 10.1345/aph.1R203. Epub 2012 Oct 23. Review.

PMID:
23092868
7.

Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an "anchor" drug?

Favalli EG, Biggioggero M, Meroni PL.

Autoimmun Rev. 2014 Nov;13(11):1102-8. doi: 10.1016/j.autrev.2014.08.026. Epub 2014 Aug 26. Review.

PMID:
25172238
8.

Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?

Levesque MC.

BioDrugs. 2012 Apr 1;26(2):65-70. doi: 10.2165/11631320-000000000-00000.

PMID:
22385403
9.

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

Choy EH, Smith C, Doré CJ, Scott DL.

Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.

PMID:
16030080
11.

Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.

Sizova L.

Br J Clin Pharmacol. 2008 Aug;66(2):173-8. doi: 10.1111/j.1365-2125.2008.03222.x. Epub 2008 May 15. Review.

12.

Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.

Devine EB, Alfonso-Cristancho R, Sullivan SD.

Pharmacotherapy. 2011 Jan;31(1):39-51. doi: 10.1592/phco.31.1.39.

PMID:
21182357
13.

Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).

Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 Nov 17;11:CD012437. Review.

PMID:
27855242
14.

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

Gaujoux-Viala C, Smolen JS, Landewé R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L.

Ann Rheum Dis. 2010 Jun;69(6):1004-9. doi: 10.1136/ard.2009.127225. Epub 2010 May 6. Review.

PMID:
20447954
15.
16.
17.
18.

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.

Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN.

Ann Intern Med. 2008 Jan 15;148(2):124-34. Epub 2007 Nov 19. Review.

PMID:
18025440
19.

The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.

Kievit W, Fransen J, Oerlemans AJ, Kuper HH, van der Laar MA, de Rooij DJ, De Gendt CM, Ronday KH, Jansen TL, van Oijen PC, Brus HL, Adang EM, van Riel PL.

Ann Rheum Dis. 2007 Nov;66(11):1473-8. Epub 2007 Apr 10. Review.

20.

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

Singh JA, Hossain A, Tanjong Ghogomu E, Kotb A, Christensen R, Mudano AS, Maxwell LJ, Shah NP, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 May 13;(5):CD012183. doi: 10.1002/14651858.CD012183. Review.

PMID:
27175934

Supplemental Content

Support Center